Clinical Study Results

What medical problems did the participants have during the study?

This section is a summary of the adverse events the participants had during the study that the study doctors thought might be related to the study drug. These adverse events are called "adverse reactions". An adverse reaction is considered "serious" when it is life-threatening, causes lasting problems, or requires hospital care.

Adverse reactions may or may not be caused by the study drug. A lot of research is needed to know whether a drug causes an adverse reaction.

The adverse reaction listed in this section is also included in the list of adverse events above.

The websites listed at the end of this summary may have more information about the adverse reaction that happened during this study.

How many participants had serious adverse reactions?

None of the participants had serious adverse reactions during the study.

How many participants had adverse reactions?

There were 2.8% of participants who had adverse reactions during the study. This was 1 out of 36 participants. This participant got 30 mg of benralizumab, and had the adverse reaction of swelling of the skin at the injection site.

How has this study helped patients and researchers?

This study helped researchers learn about the safety of benralizumab in healthy Chinese participants in China. Overall, during the study, the researchers found that benralizumab acted similarly in the body as it had during previous studies in other countries.

Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this one study. Other studies may provide new information or different results.

Further clinical studies with benralizumab are planned.